undefined undefined
NaN.000
NaN.00%
The latest update is out from ELEVAI Labs Inc. (ELAB). Elevai Labs, Inc. has se...
05-03 05:42
Elevai Labs press release (NASDAQ:ELAB): Q4 total comprehensive loss was $708,508 Revenue increased to $698,591 for the three months ended December 31, 2023, compared to $138,898 for the three months ...
03-30 00:51
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc. (NASDAQ:INMB).
01-17 01:41
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ fell 0.69% to 14,869.02. The S&P 500 also fell, dropping, 0.53% to 4,758.60.
01-16 22:49
BIDU: -5% | Baidu shares are trading lower after the company responded to recent media reports linking its large language model to key military research in China. ELAB: 126% | ELEVAI Labs Signs
01-16 21:50
Gainers Better Choice Co (AMEX:BTTR) shares moved upwards by 13.4% to $0.4 dur...
2023-12-19 05:31
Elevai Labs, Inc. (NASDAQ:ELAB), a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with Skin Sana Ltd., a Serbian corporation and premier luxury skincare
2023-12-07 22:42
Elevai Labs, Inc. (NASDAQ:ELAB) a medical aesthetic company specializing in physician-dispensed skincare, today announced that they have signed a licensing agreement with Yuva Biosciences, Inc. to research and develop
2023-11-29 22:05
重大改革!港交所实施首次公开招股“双重参与”;燕之屋通过港交所聆讯,即将启动招股;黄金开采公司集海资源递表港交所>>
2023-11-24 20:54